Legislation has been introduced to address consolidation and vertical integration in the healthcare industry, particularly with regards to pharmacy benefit managers. The bipartisan bill aims to control drug prices and reduce conflicts of interest, with potential implications for healthcare practices and costs. The specifics of the proposed legislation and its potential effects are still being reported on, with some outlets framing it as an effort to "break up" large healthcare entities.